Stereotactic ablative radiotherapy for oligometastatic breast cancer in elderly patients

被引：1

作者：

Morales-Orue, Ignacio ^{[1
,2
,3
]}

Zafra-Martin, Juan ^{[3
]}

Garcia, Laura ^{[3
]}

Chicas-Sett, Rodolfo ^{[3
]}

Castilla-Martinez, Juan ^{[3
]}

Auxiliadora Cabezon, Maria ^{[3
]}

Burgos, Javier ^{[4
]}

Lloret, Marta ^{[3
]}

Lara, Pedro C. ^{[4
,5
]}

机构：

[1] Punta Europa Hosp, Dept Radiat Oncol, Carretera Getares S-N, Algeciras 11207, Spain

[2] Punta Europa Hosp, Dept Med Oncol, Algeciras, Spain

[3] Dr Negrin Univ Hosp Gran Canaria, Dept Radiat Oncol, Las Palmas Gran Canaria, Spain

[4] San Roque Univ Hosp, Dept Oncol, Las Palmas Gran Canaria, Spain

[5] Fernando Pessoa Canarias Univ, Fac Hlth Sci, Las Palmas Gran Canaria, Spain

来源：

TRANSLATIONAL CANCER RESEARCH | 2020年 / 9卷

关键词：

Stereotactic ablative radiotherapy (SABR); elderly; oligometastatic; radiotherapy; breast; BODY RADIATION-THERAPY; QUALITY-OF-LIFE; BRAIN METASTASES; COMBINATION CHEMOTHERAPY; INTERNATIONAL SOCIETY; GERIATRIC ASSESSMENT; FOLLOW-UP; RADIOSURGERY; ONCOLOGY; SBRT;

D O I：

10.21037/tcr.2019.08.29

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Breast cancer (BC) is the principal cause of cancer-related death in women. Metastatic patients are usually treated with a systemic therapy, but clinical results are limited. Oligometastatic subjects can benefit from high-precision radiotherapy techniques to potentially achieve a complete response. Currently, there is limited evidence of stereotactic ablative radiotherapy (SABR) treatments in elderly oligometastatic cancer patients. A review of the medical literature was performed in PubMed database to assess the current role of SABR in the treatment of breast oligometastases in elderly patients. SABR represents a feasible and safe therapeutic approach in oligometastatic elderly BC patients. Further studies are required to establish the optimum patient selection and treatment scheme.

引用

页码：S197 / S206

页数：10

共 50 条

[21] Stereotactic Ablative Radiotherapy for Bone-Only Oligometastatic Breast Cancer: On a Quest to Find the Optimum Cohort
Yilmaz, M. T.
Gultekin, M.
Sari, S. Yuce
Kumru, T.
Kivanc, H.
Ozyigit, G.
Yildiz, F.
CLINICAL ONCOLOGY, 2025, 37
[22] Stereotactic Ablative Radiotherapy for Gynecological Oligometastatic and Oligoprogessive Tumors
Donovan, Elysia K.
Lo, Simon S.
Beriwal, Sushil
Chen, Hanbo
Cheung, Patrick
Keller, Andrew
Nwachukwu, Chika
Mantz, Constantine
Pond, Gregory R.
Schnarr, Kara
Swaminath, Anand
Albuquerque, Kevin
Leung, Eric
JAMA ONCOLOGY, 2024, 10 (07) : 941 - 948
[23] Neoadjuvant Stereotactic Ablative and Hypofractionated Radiotherapy for Oligometastatic NSCLC
Newman, N. B.
Anderson, J. L.
Shinohara, E. T.
Michael, P.
Attia, A.
Osmundson, E. C.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (05): : 1196 - 1196
[24] Stereotactic ablative radiotherapy for oligometastatic disease: why and how?
Widder, J.
RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S246 - S247
[25] Utilization of stereotactic ablative radiotherapy in the management of oligometastatic disease
Broomfield, J. A.
Greenspoon, J. N.
Swaminath, A.
CURRENT ONCOLOGY, 2014, 21 (03) : 115 - 117
[26] Stereotactic ablative radiatiotherapy for lung oligometastatic patients with colorectal cancer
Agolli, L.
Maurizio, V.
Luca, N.
Vitaliana, D. S.
Mattia, O. F.
RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S338 - S338
[27] The what, when and how of stereotactic ablative body radiotherapy for oligometastatic prostate cancer
Dreosti, Marcus
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 71 - 71
[28] Oligometastatic cancer in elderly patients: the “blitzkrieg” radiotherapy approachSBRT in oligometastatic elderly patients
Andrea Lancia
Gianluca Ingrosso
Alessandra Carosi
Marta Bottero
Alessandro Cancelli
Irene Turturici
Elisabetta Ponti
Riccardo Santoni
Aging Clinical and Experimental Research, 2019, 31 : 109 - 114
[29] Stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer
Verma, Vivek
Chang, Joe Y.
JOURNAL OF THORACIC DISEASE, 2018, 10 (01) : 21 - 24
[30] Outcome after stereotactic body radiotherapy (SBRT) for oligometastatic breast cancer patients
Graupner, D.
Latusek, T.
Kulik, R.
Gabrys, D.
RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S662 - S663

← 1 2 3 4 5 →